Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults

被引:0
|
作者
Jean-Yves Reginster
Charlotte Beaudart
Nasser Al-Daghri
Bernard Avouac
Jürgen Bauer
Nathalie Bere
Olivier Bruyère
Francesca Cerreta
Matteo Cesari
Mario Miguel Rosa
Cyrus Cooper
Alfonso J. Cruz Jentoft
Elaine Dennison
Anton Geerinck
Evelien Gielen
Francesco Landi
Andrea Laslop
Stefania Maggi
María Concepción Prieto Yerro
René Rizzoli
Hildrun Sundseth
Cornel Sieber
Andrea Trombetti
Bruno Vellas
Nicola Veronese
Marjolein Visser
Mila Vlaskovska
Roger A. Fielding
机构
[1] University of Liège,WHO Collaborating Center for Public Health Aspects of Musculo
[2] King Saud University,Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health Economics
[3] CHU Henri Mondor,Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science
[4] Heidelberg University,Department of Rheumatology
[5] European Medicines Agency,Center for Geriatric Medicine and Network Aging Research
[6] University of Milan,Department of Clinical Sciences and Community Health
[7] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Geriatric Unit
[8] Faculdade de Medicina da Universidade de Lisboa,Departamento de Neurociências/Laboratório de Farmacologia Clínica E Terapêutica
[9] University of Southampton,MRC Lifecourse Epidemiology Unit
[10] Hospital Universitario Ramón Y Cajal (IRYCIS),Division of Geriatrics
[11] UZ Leuven,Department of Geriatrics, Neurosciences and Orthopedics
[12] Catholic University of the Sacred Heart Rome,Scientific Office
[13] Federal Office for Safety in Health Care,Division of Bone Diseases
[14] CNR Aging Branch-IN,Department of Internal and Geriatrics Medicine, Gerontopole, CHU de Toulouse, UMR 1027 INSERM
[15] Agencia Española de Medicamentos Y Productos Sanitarios,Department of Internal Medicine, Geriatrics Section
[16] Geneva University Hospitals and Faculty of Medicine,Department of Health Sciences
[17] European Institute of Women’s Health,Medical Faculty, Department of Pharmacology and Toxicology
[18] Institute for Biomedicine of Aging Friedrich-Alexander University Erlangen-Nürnberg,Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center On Aging
[19] University Toulouse III,Gerontology and Geriatrics, Department of Public Health and Primary Care
[20] University of Palermo,undefined
[21] Vrije Universiteit Amsterdam,undefined
[22] Medical University Sofia,undefined
[23] Tufts University,undefined
[24] KU Leuven,undefined
[25] Kantonsspital Winterthur,undefined
关键词
Clinical trial; Sarcopenia; Guidelines; Recommendations; Drug registration; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 17
页数:14
相关论文
共 50 条
  • [1] Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults
    Reginster, Jean-Yves
    Beaudart, Charlotte
    Al-Daghri, Nasser
    Avouac, Bernard
    Bauer, Juergen
    Bere, Nathalie
    Bruyere, Olivier
    Cerreta, Francesca
    Cesari, Matteo
    Miguel Rosa, Mario
    Cooper, Cyrus
    Jentoft, Alfonso J. Cruz
    Dennison, Elaine
    Geerinck, Anton
    Gielen, Evelien
    Landi, Francesco
    Laslop, Andrea
    Maggi, Stefania
    Prieto Yerro, Maria Concepcin
    Rizzoli, Rene
    Sundseth, Hildrun
    Sieber, Cornel
    Trombetti, Andrea
    Vellas, Bruno
    Veronese, Nicola
    Visser, Marjolein
    Vlaskovska, Mila
    Fielding, Roger A.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (01) : 3 - 17
  • [2] Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
    Jean-Yves Reginster
    Cyrus Cooper
    René Rizzoli
    John A. Kanis
    Geoff Appelboom
    Ivan Bautmans
    Heike A. Bischoff-Ferrari
    Maarten Boers
    Maria Luisa Brandi
    Olivier Bruyère
    Antonio Cherubini
    Bruno Flamion
    Roger A. Fielding
    Andrea Ildiko Gasparik
    Luc Van Loon
    Eugene McCloskey
    Bruce H. Mitlak
    Alberto Pilotto
    Suzanne Reiter-Niesert
    Yves Rolland
    Yannis Tsouderos
    Marjolein Visser
    Alfonso J. Cruz-Jentoft
    [J]. Aging Clinical and Experimental Research, 2016, 28 : 47 - 58
  • [3] Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
    Reginster, Jean-Yves
    Cooper, Cyrus
    Rizzoli, Rene
    Kanis, John A.
    Appelboom, Geoff
    Bautmans, Ivan
    Bischoff-Ferrari, Heike A.
    Boers, Maarten
    Brandi, Maria Luisa
    Bruyere, Olivier
    Cherubini, Antonio
    Flamion, Bruno
    Fielding, Roger A.
    Gasparik, Andrea Ildiko
    Van Loon, Luc
    McCloskey, Eugene
    Mitlak, Bruce H.
    Pilotto, Alberto
    Reiter-Niesert, Suzanne
    Rolland, Yves
    Tsouderos, Yannis
    Visser, Marjolein
    Cruz-Jentoft, Alfonso J.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 28 (01) : 47 - 58
  • [4] Update in methodology and conduct of cancer clinical trials
    Therasse, P.
    Eisenhauer, E. A.
    Buyse, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (10) : 1322 - 1330
  • [5] GUIDELINES FOR THE CONDUCT OF PHARMACOLOGICAL CLINICAL TRIALS IN HAND OSTEOARTHRITIS: CONSENSUS OF A WORKING GROUP OF THE ESCEO
    Reginster, J. -Y.
    Arden, N. K.
    Haugen, I. K.
    Rannou, F.
    Cavalier, E.
    Bruyere, O.
    Branco, J.
    Chapurlat, R.
    Bassets, S. C.
    Al-Daghri, N. M.
    Dennisonm, E. M.
    Herrero-Beaumont, G.
    Laslop, A.
    Leeb, B. F.
    Maggi, S.
    Mkinsi, O.
    Povzun, A. S.
    Prieto-Alhambra, D.
    Thomas, T.
    Uebelhart, D.
    Veronese, N.
    Cooper, C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S79 - S80
  • [6] PATIENTS TO BE INCLUDED IN CLINICAL TRIALS ASSESSING THE SAFETY AND EFFICACY OF NEW CHEMICAL ENTITIES AIMING AT THE TREATMENT OF SARCOPENIA
    Rosa, M. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S58 - S59
  • [7] Current Clinical Care of Older Adults With Sarcopenia
    Roberts, Helen C.
    Dodds, Richard
    Sayer, Avan A.
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2015, 18 (04) : 493 - 498
  • [8] PRIMARY AND SECONDARY ENDPOINTS FOR CLINICAL TRIALS ASSESSING THE SAFETY AND EFFICACY OF NEW CHEMICAL ENTITIES AIMING AT THE TREATMENT OF SARCOPENIA
    Laslop, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S59 - S59
  • [9] Recruiting older adults for clinical trials
    Adams, J
    Silverman, M
    Musa, D
    Peele, P
    [J]. CONTROLLED CLINICAL TRIALS, 1997, 18 (01): : 14 - 26